GeneDx Holdings Corp.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. GeneDx Holdings Corp.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 14% to $202,566,000. The net income raised on -$175,767,000 and profit margin reached -87%. Total operating expenses were $224,284,000.

Profit Margin

GeneDx Holdings Corp. (NASDAQ:WGSWW): Profit margin
2019 196.17M -30.99M -15.8%
2020 179.32M -246.43M -137.43%
2021 212.19M -245.39M -115.64%
2022 234.69M -548.98M -233.91%
2023 202.56M -175.76M -86.77%

WGSWW Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
202.56M234.69M212.19M179.32M196.17M
Cost of revenue
141.94M261.44M228.79M175.29M113.38M
Gross profit
60.62M-26.75M-16.60M4.02M82.78M
Operating exp.
Research and development
58.26M86.20M105.16M72.7M34.91M
Selling and marketing
60.95M134.91M112.73M63.18M39.35M
Total operating expenses
224.28M430.75M429.54M246.02M113.19M
Operating income
-163.66M-667.65M-446.14M-241.99M-30.41M
Other income (expenses), net
-13.03M69.62M200.75M654K709K
Income before tax
-176.69M-598.03M-245.39M-241.34M-29.70M
Income tax expense
-926K-49.05M05.09M1.28M
Net income
-175.76M-548.98M-245.39M-246.43M-30.99M
Earnings per share
Basic EPS
-7.23-53.63-74.93-1.58M-4.26
Diluted EPS
-7.23-53.63-74.93-1.58M-4.26
Data source